Clinical Trials for Cantex Pharmaceuticals

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Cantex Pharmaceuticals

Clinical Trials (5)

NCT06831526
Neoadjuvant Chemoradiotherapy With or Without Concurrent Azeliragon in Patients With Newly Diagnosed Glioblastoma
EARLY_PHASE1Not yet recruiting
12 participants
Started: Oct 31, 2025 · Completed: Jul 31, 2030
1 condition2 sponsors1 location
NCT05789589
Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases
PHASE1/PHASE2Recruiting
46 participants
Started: Nov 17, 2023 · Completed: Aug 31, 2027
5 conditions3 sponsors1 location
NCT05986851
Azeliragon in MGMT Unmethylated Glioblastoma
PHASE2Active, not recruiting
30 participants
Started: Sep 12, 2023 · Completed: Jun 30, 2025
1 condition2 sponsors8 locations
NCT05635734
Azeliragon and Chemoradiotherapy in Newly Diagnosed Glioblastoma
PHASE1/PHASE2Active, not recruiting
18 participants
Started: Sep 5, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor4 locations
NCT05766748
Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic Cancer
PHASE1/PHASE2Recruiting
30 participants
Started: Jun 1, 2023 · Completed: May 31, 2025
1 condition1 sponsor6 locations